Dr Elyse Watkins
The purpose of this article is to review the screening tools in diagnosing heparin induced thrombocytopenia (HIT) rapidly and prevent or lessen the significant morbidity and potential mortality associated with this diagnosis. In reviewing current screening guidelines, it is provider dependent on when screening is performed. Oftentimes a HIT diagnosis is not identified until after significant morbidity has occurred, so improving the incidence of proper diagnosis is crucial in improving survival and avoiding poor outcomes.
Watters L. Efficient Testing for Heparin Induced Thrombocytopenia with Significant Platelet Drop. Lynchburg Journal of Medical Science. 2022; 4(2).
Available when accessing via a campus IP address or logged in with a University of Lynchburg email address.
Off-campus users can also use 'Off-campus Download' button above for access.